Medipal Holdings Overview

  • Year Founded
  • 1898

Year Founded

  • Status
  • Public

  • Employees
  • 21,224

Employees

  • Stock Symbol
  • 7459

Stock Symbol

  • Investments
  • 23

  • Share Price
  • $14.66
  • (As of Monday Closing)

Medipal Holdings General Information

Description

Medipal Holdings Corp distributes pharmaceuticals and health and beauty products to medical institutions and retailers. The firm operates in three segments: prescription pharmaceutical wholesale; cosmetics, daily necessities, and OTC pharmaceutical wholesale; and animal health products wholesale. The prescription pharmaceutical business generates the majority of revenue and distributes products to hospitals, clinics, and pharmacies. The cosmetics, daily necessities, and OTC pharmaceutical businesses distribute products to drugstores, convenience stores, and supermarkets. The animal health segment conducts wholesale business for animal hospitals, farms, and agricultural cooperatives. Medipal Holdings generates the vast majority of its revenue in Japan.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Stock Exchange
TKS
Corporate Office
  • 3-1-1 Kyobashi
  • Chuo-ku
  • Tokyo, 104-8461
  • Japan
+81 00-0000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Medipal Holdings Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$14.66 $14.58 $13.95 - $18.19 $3.07B 210M 505K $1.36

Medipal Holdings Financials Summary

In Thousands,
USD
TTM 31-Mar-2024 FY 2024 31-Mar-2024 FY 2023 31-Mar-2023 FY 2022 31-Mar-2022
EV 2,611,441 2,611,441 2,098,954 2,622,675
Revenue 24,629,635 24,629,635 24,818,753 29,293,445
EBITDA 641,581 641,581 625,209 636,095
Net Income 287,037 287,037 286,641 261,903
Total Assets 11,887,196 11,887,196 12,830,812 14,006,575
Total Debt 0 0 0 246,444
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Medipal Holdings Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Medipal Holdings‘s full profile, request access.

Request a free trial

Medipal Holdings Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Medipal Holdings Corp distributes pharmaceuticals and health and beauty products to medical institutions and retailers.
Drug Delivery
Tokyo, Japan
21,224 As of 2023
00000000

000000

Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu
000000000000000
Nagoya, Japan
00000 As of 0000
00000000

000 00

iscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
0000 00000000
Osaka, Japan
0000 As of 0000
00000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Medipal Holdings Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Suzuken Corporation Nagoya, Japan 00000 00000000
ONO Pharmaceutical Corporation Osaka, Japan 0000 00000000
Otsuka Holdings Corporation Tokyo, Japan 00000 00.000 00000000 00.000
Nipro Corporation Osaka, Japan 00000 00000000
To view Medipal Holdings’s complete competitors history, request access »

Medipal Holdings Patents

Medipal Holdings Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2024073843-A Order management system and order management method Pending 18-Nov-2022
US-20230005604-A1 Delivery management system Pending 22-Nov-2019 000000000
JP-7270768-B2 Delivery management system Active 22-Nov-2019 00000000000 0
JP-6842487-B2 Quality control system Active 08-Mar-2019 000000000
US-20220042854-A1 Temperature measurement device and quality control system Pending 08-Mar-2019 G01K3/005 0
To view Medipal Holdings’s complete patent history, request access »

Medipal Holdings Executive Team (3)

Name Title Board Seat Contact Info
Shuichi Watanabe Chief Executive Officer & Board Member
Toshihide Yoda Board Member & General Manager
Teiji Kitahara Executive Officer and Deputy General Manager of Business Development Department, Business Development Division
To view Medipal Holdings’s complete executive team members history, request access »

Medipal Holdings Board Members (7)

Name Representing Role Since
Kuniko Shoji Self Board Member 000 0000
Mitsuko Kagami Self Board Member 000 0000
Shuichi Watanabe Medipal Holdings Chief Executive Officer & Board Member 000 0000
Toshihide Yoda Medipal Holdings Board Member & General Manager 000 0000
Toshio Asano Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Medipal Holdings Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Medipal Holdings Investments & Acquisitions (23)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
PreMedica 31-May-2024 0000000000 000.00 Drug Discovery
MNES 30-Apr-2024 00000 0000 Other Healthcare Technology Systems 0000000 0
Kyowa Pharmaceutical 01-Mar-2024 0000000000 Pharmaceuticals
Holoeyes 01-Sep-2023 00000 0000 00.000 Medical Records Systems
Grace imaging 05-Jul-2023 Later Stage VC 00.000 Monitoring Equipment 0000000 0
You’re viewing 5 of 23 investments and acquisitions. Get the full list »

Medipal Holdings Subsidiaries (4)

Company Name Industry Location Founded
Medipal Innovation Corporate Venture Capital Tokyo, Japan 2021
PreMedica Drug Discovery Tokyo, Japan 0000
Sumitomo Pharma & Chemical Food Products Osaka, Japan 0000
Medipal Foods Food Products Tokyo, Japan 0000
To view Medipal Holdings’s complete subsidiaries history, request access »

Medipal Holdings ESG

Risk Overview

Risk Rating

Updated May, 31, 2024

18.37 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.0

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 16,191

Rank

00.0

Percentile

Healthcare

Industry

00 of 643

Rank

00.00

Percentile

Medical Distribution

Subindustry

00 of 47

Rank

00.00

Percentile

To view Medipal Holdings’s complete esg history, request access »

Medipal Holdings FAQs

  • When was Medipal Holdings founded?

    Medipal Holdings was founded in 1898.

  • Who is the CEO of Medipal Holdings?

    Shuichi Watanabe is the CEO of Medipal Holdings.

  • Where is Medipal Holdings headquartered?

    Medipal Holdings is headquartered in Tokyo, Japan.

  • What is the size of Medipal Holdings?

    Medipal Holdings has 21,224 total employees.

  • What industry is Medipal Holdings in?

    Medipal Holdings’s primary industry is Drug Delivery.

  • Is Medipal Holdings a private or public company?

    Medipal Holdings is a Public company.

  • What is Medipal Holdings’s stock symbol?

    The ticker symbol for Medipal Holdings is 7459.

  • What is the current stock price of Medipal Holdings?

    As of 24-Jun-2024 the stock price of Medipal Holdings is $14.66.

  • What is the current market cap of Medipal Holdings?

    The current market capitalization of Medipal Holdings is $3.07B.

  • What is Medipal Holdings’s current revenue?

    The trailing twelve month revenue for Medipal Holdings is $24.6B.

  • Who are Medipal Holdings’s competitors?

    Suzuken, ONO Pharmaceutical, Otsuka Holdings, and Nipro are competitors of Medipal Holdings.

  • What is Medipal Holdings’s annual earnings per share (EPS)?

    Medipal Holdings’s EPS for 12 months was $1.36.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »